Cell cycle effects of IL-10 on malignant B-1 cells

Genes and Immunity

Volumn 2, Issue 5, 2001, Pages 239-247

  Yen Chong, S ^a   Lin, Y C ^a   Czarneski, J ^b   Zhang, M ^c   Coffman, F ^a   Kashanchi, F ^d   Raveche, E ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Antisense oligonucleotides; Cell cycle; Interleukin 10; p27

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CYCLINE; INTERLEUKIN 10;

ANIMAL; ARTICLE; B LYMPHOCYTE; C57BL MOUSE; CELL CLONE; CELL CULTURE; CELL CYCLE; CELL CYCLE S PHASE; CHRONIC LYMPHATIC LEUKEMIA; DBA MOUSE; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; MACROMOLECULE; METABOLISM; MOUSE; MOUSE MUTANT; NEW ZEALAND BLACK MOUSE; PATHOLOGY;

ANIMALS; B-LYMPHOCYTES; CELL CYCLE; CLONE CELLS; CYCLINS; GENE EXPRESSION REGULATION, LEUKEMIC; INTERLEUKIN-10; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED C57BL; MICE, INBRED DBA; MICE, INBRED NZB; MICE, KNOCKOUT; OLIGONUCLEOTIDES, ANTISENSE; S PHASE; TUMOR CELLS, CULTURED;

EID: 0035430873     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363773     Document Type: Article

References (52)

1. Fayad L, Keating M, Reuben J et al. IL-6 and IL-10 levels in CLL: correlation with phenotypic characterics and outcome. Blood 2001; 97: 256-263.
2. Kamper E, Papahilis A, Angelopoulou M et al. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia. Clin Biochem 1999; 32: 639-645.
3. Aguilar-Santelises M, Gigliotti D, Osorio L et al. Cytokine expression in B-CLL in relation to disease progression and in vitro activation. Med Oncol 1999; 16: 289-295.
4. Fluckiger A, Durand I, Banchereau J. IL-10 induces apoptotic cell death of B-CLL. J Exp Med 1994; 179: 91-99.
5. Castejon R, Vargas J, Romero Y et al. Modulation of apoptosis by cytokines in B-cell chronic lymphocytic leukemia. Cytometry 1999; 38: 224-230.
6. Mentz F, Merle-Beral H, Dalloul A. Theophylline-induced B-CLL apoptosis is partly dependent on cyclin CMP production but independent of CD38 expression and endogenous IL-10 production. Leukemia 1999; 13: 780-784.
7. Morabito F, Filangeri M, Sculli G, Oliva B. In vitro modulation of bcl-2 protein expression, drug induced apoptosis and cytotoxicity by IL-10 in CLL. Haematologica 1998; 83: 1046-1048.
8. Fiorentino D, Zlotnik A, Vieira P et al. IL-10 acts on the APC to inhibit cytokine production by Th1 cells. J Immunol 1991; 146: 3444-3451.
9. Fiorentino DF, Bond MW, Mosmann TR. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med 1989; 170: 2081-2095.
10. Chen W, Zlotnik A. IL-10: a novel cytotoxic T cell differentiation factor. J Immunol 1991; 147: 528-534.
11. ti gen at the level of the cell cycle. Blood 1999; 93: 208-216.
12. Wagner EF, Hleb M, Hanna N, Sharma S. A pivotal role of cyclin D3 and cyclin dependant kinase inhibitor p27 in the regulation of IL-2, IL-4, or IL-10-mediated human B cell proliferation. J Immunol 1998; 161: 1123-1131.
13. Martin P, Hansen J, Siadak A, Nowinski R. Monoclonal antibodies recognizing normal human T lymphocytes and malignant human B lymphocytes: a comparative study. J Immumol 1981; 127: 1920-1923.
14. Royston I, Majda J, Baird S, Meserve B, Griffiths J. Human T cell antigens also found on CLL cells bearing surface IgM. J Immunol 1980; 125: 725-731.
15. Kantor AB, Stall AM, Adams S, Watanabe K, Herzenberg LA. De novo development and self-replenishment of B cells. Int Immunol 1995; 7: 55-68.
16. Haughton G, Arnold LW, Whitmore AC, Clarke SH. B-1 cells are made, not born. Immunol Today 1993; 14: 84-91.
17. Casali P, Burastero SE, Nakamura M, Inghirami G, Notkins AL. Human lymphocytes making rheumatoid factor and antibody to ssDNA belong to Leu-1+ B-Cell subset. Science 1987; 236: 77-80.
18. Casali P, Notkins A. Probing the human B cell repertoire with EBV: polyreactive antibodies and CD5+B cells. Ann Rev Immunol 1989; 7: 513-535.
19. Casali P, Notkins A. CD5+ B lymphocytes, polyreactive antibodies and the human B cell repertoire. Immunol Today 1989; 10: 364-368.
20. Forster I, Rajewsky K. Expansion and functional activity of Ly1+B cells upon transfer of peritoneal cells into allotype-congenic newborn mice. Eur J Immunol 1987; 17: 521-528.
21. Lalor P, Herzenberg L, Adams S, Stall A. Feedback regulation of murine Ly-1 B cell development. Eur J Immunol 1989; 19: 507-513.
22. Ramachandra S, Metcalf RA, Fredrickson T, Marti GE, Raveche E. Requirement for increased IL-10 in the development of B-1 lymphoproliferative disease in a murine model of CLL. J Clin Invest 1996; 98: 1788-1793.
23. Stall AM, Wells SM, Lam KP. B-1 cells: unique origins and functions. Semin Immunol 1996; 8: 45-59.
24. O'Garra A, Stapleton G, Dhar V et al. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce IL-10. Int Immunol 1990; 2: 821-832.
25. O'Garra A, Howard M. IL-10 Production by CD5 B cells. Ann NY Acad Sci 1992; 651: 182-199.
26. O'Garra A, Chang R, Go N et al. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 1992; 22: 711-717.
27. Peng B, Sherr D, Mahboudi F et al. A cultured malignant B-1 line serves as a model for Richter's syndrome. J Immunol 1994; 153: 1869-1880.
28. Fernandes H, Barchuk W, Ramachandra S et al. Regulation of CLL by IL-10: role of antisense IL-10. Oncology Reports 1995; 2: 985-989.
29. Phillips JA, Mehta K, Fernandez C, Raveche ES. The NZB mouse as a model for chronic lymphocytic leukemia. Canc Res 1992; 52: 437-443.
30. Stall A, Farinas M, Tarlinton D et al. Ly-1 B cell clones similar to human CLL routinely develop in older normal mice and young autoimmune NZB related animals. PNAS 1988; 85: 7312-7316.
31. Peng B, Mehta N, Fernandes H, Chou C, Raveche E. Growth inhibition of malignant CD5+B (B-1) cells by antisense IL-10 oligonucleotide. Leu Res 1995; 19: 159-167.
32. Ho AS, Wei SH, Mui AL, Miyajima A, Moore KW. Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol Cell Biol 1995; 15: 5043-5053.
33. Riley JK, Takeda K, Akira S, Schreiber RD. Interleukin-10 receptor signaling through the JAK-STAT pathway. Requirement for two distinct receptor-derived signals for anti-inflammatory action. J Biol Chem 1999; 274: 16513-16521.
34. Wehinger J, Gouilleux F, Groner B et al. IL-10 induces DNA binding activity of three STAT proteins (Stat1, Stat3, and Stat5) and their distinct combinatorial assembly in the promoters of selected genes. FEBS Lett 1996; 394: 365-370.
35. Castro A, Sengupta TK, Ruiz DC, Yang E, Ivashkiv LB. IL-4 selectively inhibits IL-2-triggered Stat5 activation, but not proliferation, in human T cells. J Immunol 1999; 162: 1261-1269.
36. Kaplan MH, Daniel C, Schindler U, Grusby MJ. Stat proteins control lymphocyte proliferation by regulating p27Kip1 expression. Mol Cell Biol 1998; 18: 1996-2003.
37. Sanchez-Beato M, Camacho F, Martinez-Montero J et al. Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells. Blood 1999; 94: 765-772.
38. Vrhovac R, Delmer A, Tang R et al. Prognostic significance of the cell cycle inhibitor p27Kip1 in chronic B-cell lymphocytic leukemia. Blood 1998; 91: 4694-4700.
39. Kwon TK, Nagel JE, Buchholz MA, Nordin AA. Characterization of the murine cyclin-dependent kinase inhibitor gene p27Kip1. Gene 1996; 180: 113-120.
40. Seldin M, Conroy J, Steinberg A, d'Hoosteleare L, Raveche E. Clonal expansion of abnormal B cells in old NZB mice. J Exp Med 1987; 166: 1585-1590.
41. Scheffold A, Assenmacher M, Reiners-Schramm L, Lauster R, Radbruch A. Hish sensitivity immunofluorescence for detection of pro-and anti-inflammatory cytokines gamma interferon and IL-10 on the surface of cytokine-secreting cells. Nat Med 2000; 6: 107-110.
42. Ito S, Ansari P, Sakatsume M et al. Interleukin-10 inhibits expression of both interferon alpha-and interferon gamma-induced genes by suppressing tyrosine phosphorylation of STAT1. Blood 1999; 93: 1456-1463.
43. Morinobu A, Kumagai S, Yanagida H et al. IL-10 suppresses cell surface CD23/Fc epsilon RII expression, not by enhancing soluble CD23 release, but by reducing CD23 mRNA expression in human monocytes. J Clin Immunol 1996; 16: 326-333.
44. Itoh K, Hirohata S. The role of IL-10 in human B cell activation, proliferation, and differentiation. J Immunol 1995; 154: 4341-4350.
45. Tangye SG, Weston KM, Raison RL. Interleukin-10 inhibits the in vitro proliferation of human activated leukemic CD5+ B-cells. Leuk Lymphoma 1998; 31: 121-130.
46. Cheng M, Sexl V, Sherr CJ, Roussel MF. Assembly of cyclin D-dependent kinase and titration of p27Kip1 regulated by mitogen-activated protein kinase kinase (MEK1). Proc Natl Acad Sci USA 1998; 95: 1091-1096.
47. Muller D, Bouchard C, Rudolph B et al. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes. Oncogene 1997; 15: 2561-2576.
48. Byrd JC, Shinn C, Ravi R et al. Depsipeptide (FR901228): a novel therapeutic agent with selective, in vitro activity against human B-cell chronic lymphocytic leukemia cells. Blood 1999; 94: 1401-1408.
49. Karras JG, Wang Z, Huo L et al. Signal transducer and activator of transcription-3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med 1997; 185: 1035-1042.
50. Niu G, Heller R, Catlett-Falcone R et al. Gene therapy with dominant-negative Stat3 suppresses growth of the murine melanoma B16 tumor in vivo. Cancer Res 1999; 59: 5059-5063.
51. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
52. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.